SOURCE: Sunwin International Neutraceuticals, Inc.

April 04, 2007 08:30 ET

Sunwin International Neutraceuticals Announces Its Hypericin-Based Veterinary Disinfectant Is Proven to Be Effective in Killing Bird Flu Virus (H5N1) in an Independent Study

QUFU, CHINA -- (MARKET WIRE) -- April 4, 2007 -- Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie sweetener (Stevia) in China, announced today its Hypericin-based veterinary disinfectant has proven to be effective in killing 100% of bird flu virus (H5N1) in research tests involving H5N1-infected Chicken embryos. The research was independently conducted by a group of scientists from Ha'erbing Veterinary Institute of the Chinese Academy of Agricultural Sciences, Animal Influenza Laboratory of the Ministry of Agriculture, and National Bird Flu Reference Laboratory. Hypericin is a derivative of St. Johns Wort.

The test results demonstrated that Sunwin's Hypericin-based veterinary disinfectant eliminates 100% of bird flu virus (H5N1) in the infected chicken embryos within 10 minutes when the Hypericin-based disinfectant was diluted at ratios of 1:5, 1:10, 1:25 and 1:50. No significant toxicities to healthy chicken embryos were observed when the disinfectant was diluted at these same levels.

In November 2005, the Department of Livestock Farming for Shandong Province Government submitted a fast-track application to the Livestock Farming Bureau of China Ministry of Agriculture for approval of Hypericin related products as a class one new veterinary medicine to treat strands of the avian flu virus. This independent study was a requirement of the approval process for the application.

Laiwang Zhang, President and Chairman of Sunwin International Neutraceuticals, commented "We are extremely pleased with these independent study results. We believe they validate the effectiveness of Hypericin which will help pave the way for approval of our Hypericin-based veterinary disinfectant as class one veterinary medicine in China. If the use of this medicine is determined to be the best way to prevent and deter the spread of bird flu virus by tens of millions of poultry farmers in China, the economic impact on our company could be enormous as we are one of only a few manufacturers of these products in China."

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN) is engaged in the areas of essential traditional Chinese medicine, low-calorie natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumer to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. For more info about Sunwin, please visit

Safe Harbor Statement

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations or beliefs, including, but not limited to, statements concerning the Company's operations, financial performance and, condition. For this purpose, statements that are not statements of historical fact may be deemed to be forward-looking statements. The Company cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, but not limited to, the impact of competitive products, pricing and new technology; changes in consumer preferences and tastes; and effectiveness of marketing; changes in laws and regulations; fluctuations in costs of production, and other factors as those discussed in the Company's reports filed with the Securities and Exchange Commission from time to time. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Contact Information